Aevi Genomic is a biopharmaceutical company that develops novel therapies for genetic disorders in adults and children. Read more

5 Followers on Owler
5 Followers on Owler
5 Followers on Owler
5 Followers on Owler

Aevi Genomic is a biopharmaceutical company that develops novel therapies for genetic disorders in adults and children. Read more

CEO Avatar

President & CEO

Michael F. Cola

CEO Approval Rating

85/100

Founded:

2000

Status:

PrivateSubsidiary of Cerecor, Inc.

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Contextual Genomics is one of Aevi Genomic Medicine's top competitors. Contextual Genomics was founded in 2012 in Vancouver, British Columbia. Contextual Genomics operates in the Biotechnology industry. Contextual Genomics generates $5.4M more revenue than Aevi Genomic Medicine.

OpGen is a top competitor of Aevi Genomic Medicine. OpGen was founded in 2002, and is headquartered in Gaithersburg, Maryland. OpGen is in the Biotechnology industry. OpGen generates $1.6M more revenue vs. Aevi Genomic Medicine.

Congenica is seen as one of Aevi Genomic Medicine's top competitors. Congenica is headquartered in Cambridge, England, and was founded in 2012. Congenica is in the Biotechnology field. Congenica generates 105% the revenue of Aevi Genomic Medicine.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 14 a good estimate for Aevi Genomic Medicine's Employee count?

Acquisitions

No recent acquisitions found related to Aevi Genomic Medicine

Aevi Genomic Medicine Funding History

$265K$4.7M$14.2M$17.4M$45.4M

Since Aevi Genomic Medicine was founded in 2000, it has participated in 6 rounds of funding. In total Aevi Genomic Medicine has raised $45.4M. Aevi Genomic Medicine's last funding round was on Oct 2017 for a total of $28.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Oct 2017
$28M
-
Equity
Oct 2015
$3.2M
-
Equity
Jun 2012
$9.5M
-
Debt
Sep 2010
$4M
-
Equity
May 2010
$430.4K
-

Since Aevi Genomic Medicine was founded in 2000, it has participated in 6 rounds of funding. In total Aevi Genomic Medicine has raised $45.4M. Aevi Genomic Medicine's last funding round was on Oct 2017 for a total of $28.0M

Investments

No recent investments found related to Aevi Genomic Medicine

Aevi Genomic Medicine News

February 4, 2020The Business Journals: Washington, D.C.

Cerecor completes acquisition of Pennsylvania biopharma

Maryland biopharmaceutical company Cerecor Inc. has completed its acquisition of Wayne, Pennsylvania-... See more »
February 3, 2020FIRSTWORD PHARMA

Cerecor and Aevi Genomic Medicine Complete Merger

ROCKVILLE, Md., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical co... See more »
December 6, 2019The Pharma Letter

Cerecor to acquire Aevi Genomic Medicine

US rare and orphan diseases drug developer Cerecor has entered into a definitive merger agreement to.... See more »
December 6, 2019pipelinereview

Cerecor to Acquire Aevi Genomic Medicine

Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development ... See more »
October 15, 2019BioSpace

Aevi Genomic Medicine, Inc. Receives Positive Nasdaq Listing Determination

Aevi Genomic Medicine, Inc. announced that the Nasdaq Hearings Panel has agreed to the transfer of th... See more »
August 7, 2019Contract Pharma

Aevi Genomic Medicine, AstraZeneca Enter Into License Agreement

Plans to initiate Phase 2 trial for treatment of Adult Onset Still's Disease and other serious rare a... See more »
January 5, 2019Zolmax News

Aevi Genomic Medicine Inc (GNMX) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Aevi Genomic Medicine Inc (NASDAQ:GNMX) have been given an average broker rating score of 3... See more »

Aevi Genomic Medicine Press Releases

November 2, 2017PR Newswire

Aevi Genomic Medicine Reports Third Quarter 2017 Financial Results

PHILADELPHIA, Nov. 2, 2017 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) a... See more »
October 17, 2017PR Newswire

Aevi Genomic Medicine Announces Completion of $28 Million Private Placement

PHILADELPHIA, Oct. 17, 2017 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX)(the "Company")... See more »
September 5, 2017Blackbird

Aevi Genomic Medicine to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

PHILADELPHIA, Sept. 5, 2017 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) ... See more »
August 10, 2017ldmicro

Aevi Genomic Medicine Announces Agreement for $28 Million Private Placement

Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") today announced the execution of a definit... See more »
November 22, 2016Marketwired

Medgenics to Present at the 28th Annual Piper Jaffray Healthcare Conference

PHILADELPHIA, PA--(Marketwired - Nov 22, 2016) - Medgenics, Inc. (NASDAQ: MDGN) today announced that ... See more »
November 9, 2016Marketwired

Medgenics to Present at the Jefferies London Healthcare Conference

PHILADELPHIA, PA--(Marketwired - Nov 9, 2016) - �Medgenics, Inc. (NASDAQ: MDGN) today announced tha... See more »

Social Media

Headquarters

435 Devon Park Dr Suite 715

Wayne, Pennsylvania19087

1-610-254-4201

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Aevi Genomic is a biopharmaceutical company that develops novel therapies for genetic disorders in adults and children. Aevi Genomic Medicine was founded in 2000. Aevi Genomic Medicine's headquarters is located in Wayne, Pennsylvania, USA 19087. It ha...

CEO

Aevi Genomic Medicine's President & CEO, Michael F. Cola, currently has an approval rating of 85%. Aevi Genomic Medicine's primary competitors are Contextual Genomics, OpGen & Congenica.

Website

aevigenomics.com

Frequently Asked Questions about Aevi Genomic Medicine

  1. When was Aevi Genomic Medicine founded?

    Aevi Genomic Medicine was founded in 2000
  2. Who is Aevi Genomic Medicine's CEO?

    Aevi Genomic Medicine's CEO is Michael F. Cola
  3. How much revenue does Aevi Genomic Medicine generate?

    Aevi Genomic Medicine generates $2.1M in revenue
  4. How much funding does Aevi Genomic Medicine have?

    Aevi Genomic Medicine has historically raised $45.4M in funding
  1. Where is Aevi Genomic Medicine's headquarters?

    Aevi Genomic Medicine's headquarters is in Wayne Pennsylvania, USA
  2. How many employees does Aevi Genomic Medicine have?

    Aevi Genomic Medicine has 14 employees
  3. What sector does Aevi Genomic Medicine operate in?

    Aevi Genomic Medicine is in Pharmaceuticals
  4. Who are Aevi Genomic Medicine's competitors?

    Aevi Genomic Medicine's top competitors are Contextual Genomics, OpGen, Congenica